Head-to-head · Cost-Efficiency Index
Fresh Day Meds vs NuuVim
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Fresh Day Meds
Shoppers comfortable prepaying a 3-month quarterly bundle for the lowest per-month rate.
Visit Fresh Day MedsNuuVim
Cost-first shoppers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.
Visit NuuVimThe verdict
Fresh Day Meds and NuuVim tie on the Cost-Efficiency Index at 70/100, so neither wins outright on the numbers. For most shoppers we'd start with Fresh Day Meds (ranked #87, a hair above #88) — Shoppers comfortable prepaying a 3-month quarterly bundle for the lowest per-month rate. But NuuVim is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Fresh Day Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Fresh Day Meds | NuuVim |
|---|---|---|
| Cost-Efficiency Index | 70/100 | 70/100 |
| Semaglutide / mo | $140/mo (compounded) | $79/mo (all doses, 3-mo plan, new patients only, compounded) |
| Tirzepatide / mo | $179/mo (compounded) | $133/mo (all doses, 3-mo plan, new patients only, compounded) |
| Semaglutide / yr (modeled) | $1,680 | $948 |
| Tirzepatide / yr (modeled) | $2,148 | $1,596 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Yes |
| Rank here | #87 | #88 |
Fresh Day Meds
70/100Where the value is
- No membership fees and free expedited shipping stated on-site
- LegitScript seal displayed
- Transparent quarterly-renewal totals shown next to the monthly-equivalent price, so the prepay isn't hidden
The tradeoffs
- The 'from $99/mo' headline is a new-patient-only, low-dose, 3-month-prepay price ($299 upfront) — the flat month-to-month rate is $140/mo
- No named compounding pharmacy or medical director/prescriber disclosed
NuuVim
70/100Where the value is
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
The tradeoffs
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.